HOME >> BIOLOGY >> NEWS
Breakthroughs lead to better understanding in prevention of transfusion-transmitted infection

(SAN DIEGO, Calif., December 8, 2003) While the nation's blood supply is safe overall and there is a relatively small likelihood that transfusion recipients will acquire a transmitted disease, there are still risks involved when transferring one person's blood into another. The advent of new diseases, such as West Nile Virus (WNV), increases the need for further clinical vigilance and improved screening methods.

The blood supply is currently inspected in minipools with nucleic acid testing for HIV, hepatitis C virus (HCV) and WNV, but there is now a movement toward screening individual blood donations with such examinations. Additionally, researchers are learning more about reducing the risk of transferring specific diseases that may not affect healthy individuals but may seriously hurt immunocompromised patients, who often receive donated blood. Several studies of this nature are being presented during the 45th Annual Meeting of the American Society of Hematology.

"Modern medicine has contributed exponentially to the quality of medical care and has provided us with the opportunity to conduct successful blood transmissions to save millions of lives every year," said Stanley Schrier, M.D., President-Elect of the American Society of Hematology and Active Emeritus Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. "However, it remains duly important that we not compromise our patients' overall well-being while trying to improve their situation."

Yield of West Nile Virus RNA Screening of U.S. Blood Donors (Abstract 190)

West Nile Virus (WNV) has spread rapidly in the United States over the past four years. In 2002, hospitals documented the first cases of WNV linked to blood transfusions, leading to an intense effort to develop and implement a screening program. Researchers from Blood Systems Laboratories, Tempe, Ariz., have introduced nuc
'"/>

Contact: Aimee Frank
amf@spectrumscience.com
202-955-6222
American Society of Hematology
8-Dec-2003


Page: 1 2 3 4 5

Related biology news :

1. Breakthroughs in acoustic tracking shine new light on the lives of fish
2. Advancing Biotechnology Breakthroughs
3. Nations Leading Biomedical Researchers Present Breakthroughs in Liver Disease
4. Environmental Technology Breakthroughs Forecast -- Year 2008
5. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
6. Microbes eat their way to better concrete
7. Computer database being developed at Temple will allow for better inventory of chemicals
8. New and better drugs for tuberculosis goal of UH professor
9. Ants protect plants better when jacked up on nectar
10. The blind really do hear better
11. Microarrays, key genome expression trackers, work better when probes are sequence-verified

Post Your Comments:
(Date:4/17/2014)... trials to treat tuberculosis could be the basis for ... bacteria, fungal infections and parasites, yet evade resistance, according ... collaborators. , Led by U. of I. chemistry professor ... drug SQ109 attacks the tuberculosis bacterium, how the drug ... to malaria and how targeting multiple pathways reduces ...
(Date:4/17/2014)... word for chili peppers. Information about archaeological remains of ... of the appearance of words for chili peppers in ... domesticated and highlight the value of multi-proxy data analysis. ... of nine papers presented in a special feature issue ... Sciences on plant and animal domestication edited by ...
(Date:4/17/2014)... West Orange, NJ. April 16, 2014. Kessler Foundation ... for $1.8 million from the Department of Defense ... PhD, is principal investigator for the randomized, double-blinded, ... to improve bone and muscle strength after spinal ... Human Performance & Engineering Research at Kessler Foundation. ...
Breaking Biology News(10 mins):Multitarget TB drug could treat other diseases, evade resistance 2Chickens to chili peppers 2Chickens to chili peppers 3Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2
(Date:1/15/2014)... , Jan. 15, 2014 TaiGen Biotechnology Company, ... exclusive agreement with R-Pharm, a leading Russian pharmaceutical company, ... the Russian Federation , ... Independent States (CIS). Nemonoxacin is a novel antibiotic for the ...
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging ... to serve the wound care market. , Free report ... was restructured with a seasoned management team and Board, ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 iLab Solutions, the ... as the new Director of Product Strategy. In this role, ... as iLab sub-teams to guide in the development of iLab ... provides the maximum possible benefit to the scientific community by ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
Cached News: